Almost 30,000 people in England with chronic obstructive pulmonary disease (COPD) could soon have access to a biologic treatment, Sanofi and Regeneron's Dupixent, after it was recommended for use by ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By James Austin James Austin is a writer covering games and hobbies, which means ...